Healio (8/4) reported, “Clozapine use in treatment-resistant schizophrenia was associated with lower all-cause mortality and self-harm rates,” researchers found after evaluating “a population-based cohort of 2,370 individuals with treatment-resistant schizophrenia from January 1996 until death, first episode of self-harm, emigration, or June 2013.” The findings were published online July 28 in the American Journal of Psychiatry, a publication of the American Psychiatric Association.
Related Links:
— “Mortality, self-harm lower with clozapine use in schizophrenia,” Wimberley T, et al., Healio, August 4, 2017.